Illumicell

Allston, United States Founded: 2023 • Age: 3 yrs
AI-powered fertility screening tools are provided for clinics.

About Illumicell

Illumicell is a Healthcare company based in Allston (United States) founded in 2023 by Michel Bielecki, Jeyla Sadikova, and Loup Cordey. It operates as an AI-powered fertility screening tools are provided for clinics. Illumicell has raised $2.02 million across 2 funding rounds from investors including Techstars, Kofa Healthcare and Phoenix Investment Club. Its chief executive is Michel Bielecki. Illumicell offers products and services including AI Semen Analysis Platform and Cellular Insights Tool. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Alife Health, Fairtility, LEVY Health, Cercle and Kai Health and 4 more; 6 of its 9 listed competitors have raised funding.

Company details

Illumicell was founded in 2023 and is based in Allston, United States. AI-driven fertility screening tools are supplied to clinics and healthcare providers in the reproductive health sector. Clinical operations are streamlined through these solutions, while business growth is supported and fertility care is facilitated. Operations center on integrating technology into healthcare workflows for improved efficiency.

  • Headquarters Allston, United States
  • Founders Michel Bielecki, Jeyla Sadikova, Loup Cordey
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website illumicell.ai
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $2.02M (USD)

    in 2 rounds

  • Latest Funding Round
    $2M (USD), Seed

    Mar 2025

  • Investors
    Techstars

    & 4 more

Products & Services of Illumicell

Illumicell offers a comprehensive portfolio of products and services, including AI Semen Analysis Platform and Cellular Insights Tool.

AI Semen Analysis Platform
Health Diagnostics

Uses AI to analyze semen for biomarkers linked to health issues.

Cellular Insights Tool
Data Analysis

Processes cellular data to provide personalized health diagnostics.

Funding Insights of Illumicell

Illumicell has successfully raised a total of $2.02M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.02M
  • Total Rounds 2
  • Last Round Seed β€” $2M
  • First Round $19,998

    (Jun 2023)

  • Investors Count 5

All 2 funding rounds of Illumicell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2025$2MSeed––
Jun 2023$19,998Seed–Techstars
–
Valuation history

5 investors in total: 4 institutional and 1 angel.

Investors in Illumicell

Illumicell has secured backing from 5 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Techstars, Kofa Healthcare and Phoenix Investment Club.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Kofa Healthcare is engaged in funding healthcare and biotech innovations.
–kofahealthcare.com-
Angel network and venture capital fund focused on multiple sectors
–phoenixclub.vcSan Francisco, United States
Startups are accelerated globally without sector restrictions through structured programs.
2006techstars.comNew York, United States
Platform facilitates clinician investments in early-stage MedTech innovations and startup funding.
2021medtechsyndicates.comDublin, Ireland

Jeremy Teoh

-
–unknown_bfe4b379d7e24a83b-
Premium access

Investor details for Illumicell

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Illumicell

3 people are tracked at Illumicell (3 in leadership).

NameRoleGroup
Michel Bielecki
Co-Founder & CEOLeadership
Jeyla Sadikova
Co-FounderLeadership
Loup Cordey
Co-FounderLeadership
Premium access

Complete people profiles for Illumicell

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Illumicell

3 dated milestones of Illumicell across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Illumicell is founded.
  2. Funding First funding round of $20K.
  3. Funding Latest funding round, Seed, of $2.0M.

Competitors of Illumicell

Illumicell has 9 listed competitors in our database, 6 of them funded. They include Alife Health, Fairtility, LEVY Health, Cercle and Kai Health, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
alifehealth.com2020Cambridge, United States$31.5M23
AI-based fertility care tools are supplied to clinicians for analysis.
fairtility.com2019Tel Aviv, Israel$15M–
AI and cloud-based diagnosis tools for fertility treatments are developed.
levy.health2020Berlin, Germany$7.26M–
Precision fertility diagnostics are supported by clinical decision software.
cercle.ai2020Frisco, United States$10.2M–
Cercle is focused on advancing women's healthcare through AI-driven insights.
kaihealth.tech2021Seoul, South Korea––
Personalized fertility treatment solutions are provided using AI technology.
lifewhisperer.com2016San Francisco, United States––
AI-based embryo monitoring for IVF procedures is provided.
weareclaire.health2020San Francisco, United States$100,000–
Integrative health management platform for fertility treatment is provided.
episona.com2013Los Angeles, United States$4M–
Male infertility is diagnosed through epigenetic analysis of sperm samples.
cellpro.com.cn2012Ningbo, China––
Assisted reproductive technology products are developed for diagnosis and treatment.
Premium access

Detailed competitors of Illumicell

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Illumicell

The website of Illumicell (illumicell.ai) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▼ 30% vs previous month

Similar websites

Websites whose visitors overlap most with Illumicell. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lifesciencemarketresearch.com
lifesciencemarketresearch.com
100%
–#1,404,464–

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as Illumicell (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Illumicell

Illumicell was founded in 2023.

Illumicell is headquartered in Allston, United States. It is registered at Allston, Massachusetts, United States.

Michel Bielecki is the current CEO of Illumicell. They have also founded this company.

Illumicell is a funded company, having raised a total of $2.02M across 2 funding rounds to date. The company's 1st funding round was a Seed of $20K, raised on Jun 2023.

Illumicell was founded in 2023 and is based in Allston, United States. AI-driven fertility screening tools are supplied to clinics and healthcare providers in the reproductive health sector. Clinical operations are streamlined through these solutions, while business growth is supported and fertility care is facilitated. Operations center on integrating technology into healthcare workflows for improved efficiency.

Illumicell's top competitors include Alife Health, LEVY Health and Cercle.

Illumicell offers AI Semen Analysis Platform and Cellular Insights Tool.

Illumicell has 5 investors. Key investors include Techstars, Kofa Healthcare, Phoenix Investment Club, MedTech Syndicates, and Jeremy Teoh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available